According to the FDA's official guidance (updated April 2026 at fda.gov), the semaglutide injection shortage was resolved on February 21, 2025, and the transitional exemption windows for compounders operating under the shortage exemption subsequently ended - for 503A pharmacies by April 22, 2025, and for 503B outsourcing facilities by May 22, 2025
Science 365 (6450), eaau6499
Expanding Healthcare Services Future Plans McCall expresses a desire to expand their practice into Canada and offers non-medical consultations for European patients
Loose stools or constipation
Were dedicated to helping you achieve your wellness and beauty goals
However, the medical community isnt speaking with one voice on this issue, and understanding the different perspectives is crucial for any nutritionist working in this field